Nutraceutical Contract Manufacturing Services Global Market Report 2023 – By Product (Dietary Supplements, Functional Food And Beverages), By Dosage Form (Tablets, Capsules, Liquid Oral, Powder In Sachet Or Jar, Gummies, Energy Bars, Other Forms), By End User (Big Pharmaceutical Companies, Small And Medium Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users) – Market Size, Trends, And Global Forecast 2023-2032

Biopharmaceutical contract manufacturing refers to a process in which a biopharmaceutical company hires a third-party manufacturer to produce their drugs or biologic products on their behalf. It is utilised when pharmaceutical businesses employ the facilities of other companies to manufacture pharmaceuticals under their own brand. It is identical to private label or third-party production. The main products of biopharmaceutical contract manufacturing include biologics, monoclonal antibodies (mABs), recombinant proteins, vaccines, antisense, mai and molecular therapy and biosimilars. Monoclonal antibodies (MABs) refer to lab-made proteins that function in human bodies similarly to antibodies. They are sourced from mammalian and non-mammalian and the services offered include process development, fill and finish operations, analytical and QC studies and packaging for applications in clinical and commercial purposes. The global biopharmaceuticals contract manufacturing market is segmented - 1) By Product: Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars 2) By Source: Mammalian, Non-mammalian 3) By Service: Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging 4) By Application: Clinical, Commercial The global biopharmaceuticals contract manufacturing market size is expected to grow from $16.54 billion in 2022 to $18.31 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global biopharmaceuticals contract manufacturing market size is expected to reach $26.88 billion in 2027 at a CAGR of 10%. The increasing demand for biologics is expected to propel the growth of the biopharmaceutical contract manufacturing market going forward. Biologics are products manufactured from living organisms or containing pieces made from them, such as those derived from humans, animals, or microbes, using biotechnology. They are utilized to treat various diseases and ailments and provide the most cutting-edge therapies currently available. The biologics contract manufacturing industry is expanding due to the expanding biologics pipeline, the complexity of the production process, and firms focusing on their core capabilities, several pharmaceutical and biotechnology businesses are currently outsourcing a wide range of tasks, from commercial-scale manufacturing to early-stage drug research. For instance, in December 2021, IQVIA Inc, a US-based provider of commercial outsourcing and biopharmaceutical development services, released a report stating that by 2021, biologics will account for 34% of all medical expenditures in Europe, with a value of €78.6 billion (US $86.29 billion) with a five-year compound annual growth rate (CAGR) of 10.5%. Therefore, the increasing demand for biologics is driving the growth of the biopharmaceutical contract manufacturing market. Major players in the biopharmaceuticals contract manufacturing market are Boehringer Ingelheim GmbH, Lonza Group, Inno Biologics Sdn Bhd, Rentschler Biotechnologie GmbH, Samsung BioLogics, AGC Biologics, ProBioGen AG, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific Inc., Binex Co. Ltd., AbbVie Inc., Catalent Inc, Pfizer Inc., Merck KGaA, Pressure BioSciences, Novartis AG, Cambrex Corporation, and Emergent BioSolutions. Product innovations are a key trend gaining popularity in the biopharmaceuticals contract manufacturing market. Major companies operating in the biopharmaceutical contract manufacturing market are developing innovative products to sustain their position in the market. For instance, in February 2023, Thermo Fisher Scientific, a US-based biotechnology research company, and Elektrofi, a US-based biotechnology company specializing in drug formulation and delivery innovations, entered into a strategic contract manufacturing agreement to support the commercial production of Elektrofi's ground-breaking ultra-high concentration subcutaneous products. Elektrofi's proprietary microparticle technology enables small-volume injections of biologics such as monoclonal antibodies, therapeutic proteins, and other large-molecule medications important for human health. Elektrofi's platform technology allows patients to self-inject medicines at home rather than in a hospital setting, overcoming the difficulties of administering biologic-based medications. In June 2022, Asahi Kasei Medical Co. Ltd., a Japan-based chemical company, acquired Bionova Scientific, LLC, for an undisclosed amount. With the acquisition of Bionova Scientific, Asahi Kasei Medical will be able to expand its bioprocess business by adding a biopharmaceutical CDMO (contract development and manufacturing organization) and reaching a broader customer base, including those developing the most cutting-edge next-generation biopharmaceuticals. Bionova Scientific, LLC is a US-based company that offers biopharmaceutical firms contract process development services and GMP-compliant contract manufacturing services. North America was the largest region in the biopharmaceutical contract manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the global biopharmaceuticals contract manufacturing market forecast period. The regions covered in the global biopharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biopharmaceutical contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The biopharmaceutical contract manufacturing market includes revenues earned by entities providing services such as formulation development, GMP manufacturing and supply chain management. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The biopharmaceutical contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides biopharmaceutical contract manufacturing optical components market statistics, including biopharmaceutical contract manufacturing optical components industry global market size, regional shares, competitors with a biopharmaceutical contract manufacturing optical components market share, detailed biopharmaceutical contract manufacturing optical components market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical contract manufacturing optical components industry. This biopharmaceutical contract manufacturing optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Electronic contract manufacturing and design services are defined as a form of engineering and manufacturing outsourcing services that companies use to test, manufacture and distribute products, and provide return and repair services. The complexity and wide variety of electronic devices make OEMs choose electronic contract manufacturers to outsource their products for the efficient manufacturing process and to focus on internal operations such as new product development with greater complexity and higher margins. The main types of electronic contract manufacturing and design services are designing, assembly, manufacturing, and others. Designing refers to a method of human expression that follows a system of highly developed procedures in order to imbue objects, performances, and experiences with significance. These are used in various applications such as consumer electronics, electronic components, computers & peripherals, industrial electronics, others by various end-user industries including healthcare, automotive, industrial, aerospace and defense, IT and telecom, power and energy, consumer electronics, others. The global electronic contract manufacturing and design services market is segmented - 1) By Type: Designing, Assembly, Manufacturing, Other Types 2) By Application: Consumer Electronics, Electronic Components, Computers & Peripherals, Industrial Electronics, Other Applications 3) By End User: Healthcare, Automotive, Industrial, Aerospace and Defense, IT and Telecom, Power and Energy, Consumer Electronics, Other End Users The global electronic contract manufacturing and design services market size will grow from $429.85 billion in 2022 to $477.89 billion in 2023 at a compound annual growth rate (CAGR) of 11.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global electronic contract manufacturing and design services is expected to grow to $732.34 billion in 2027 at a CAGR of 11.3%. The increase in demand for consumer electronics is significantly contributing to the growth of the electronic contract manufacturing and design services market. Consumer electronics are the instruments, machines, and apparatus that are used by end-users or consumers on a daily basis that provide one or more functionalities in a home or for a particular individual for professional or personal use. Consumer electronics include televisions, computers, laptops, smartphones, watches, and tablets. The rising demand for consumer electronics increases the need for outsourcing of electronics components from electronic contract manufacturing companies, which reduces the cost of manufacturing, assembling of products, and design services and increases operational efficiency in manufacturing. For instance, according to the Consumer Electronics and Appliances Manufacturers Association (CEAMA), the Indian appliances and consumer electronics market size is expected to grow more than two-folds in the next five to six years and reach up to $26.81 billion. Also, according to ClearSale, the revenue in the consumer electronics segment is anticipated to increase by more than USD360 billion in 2020 and more than USD450 billion by 2024. Therefore, the increase in demand for consumer electronics is driving the growth of electronic contract manufacturing and design services. Major players in the electronic contract manufacturing and design services market are Flex Ltd., Hon Hai Precision Industry Co., Ltd., Benchmark Electronics, Celestica Inc., Venture Corporation Limited, Fabrinet, Plexus Corp., Sanmina Corporation, Compal Electronics, Inc., Universal Scientific Industrial Co., Ltd., New Kinpo Group, Creating Technologies LP, Shenzhen Kaifa Technology, LCS Company, and Bassett Industries, Inc. Strategic partnerships and collaborations are the key trends being followed by the companies operating in the electronic contract manufacturing and design services market. This is due to the presence of a large number of electronics manufacturing companies operating in the market and their desire to extend their growth in new areas to be a leader in the market. For instance, in September 2021, BioSig Technologies, Inc., an American medical device company, and Plexus Corp., an American-based contract electronics manufacturing company, formed a technological and strategic partnership for the commercialization and development of a new biomedical signal processing platform, which provides a full range of applications in arrhythmia care for BioSig’s subsidiary NeuroClear Technologies. In March 2020, Universal Scientific, a China-based electronic design and manufacturing services company, acquired Asteelfash Group for an undisclosed amount. Through this acquisition, Universal Scientific aims to expand its overseas manufacturing sites and operational systems to meet the needs of the European and US markets. Asteelfash Group is a France-based multinational electronics contract manufacturing company. Asia-Pacific was the largest region in the electronics contract manufacturing and design services market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the electronic contract manufacturing and design services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the electronic contract manufacturing and design services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The electronic contract manufacturing and design services market includes revenues earned by entities by providing services such as electronic design and engineering, electronics assembly, electronic manufacturing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The electronic contract manufacturing and design services research report is one of a series of new reports from The Business Research Company that provides electronic contract manufacturing and design services statistics, including electronic contract manufacturing and design services industry global market size, regional shares, competitors with electronic contract manufacturing and design services share, detailed electronic contract manufacturing and design services segments, market trends and opportunities, and any further data you may need to thrive in the electronic contract manufacturing and design services industry. This electronic contract manufacturing and design services research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Fill-finish pharmaceutical contract manufacturing refers to the outsourcing of the final stages of the pharmaceutical manufacturing process to specialized contract manufacturing organizations (CMOs). The main product types of fill-finish pharmaceutical contract manufacturing are prefilled syringes, vials, cartridges, and other products. Prefilled syringes are ready-to-use syringes that come pre-filled with a specific dose of medication and are aseptically filled by fill-finish pharmaceutical contract manufacturing processes, ensuring precise dosing, sterility, and quality control. Fill-finish pharmaceutical contract manufacturing is also used for large molecules and small molecules by end-users such as biopharmaceutical companies and pharmaceutical companies. The global fill-finish pharmaceutical contract manufacturing market is segmented - 1) By Product Type: Prefilled Syringes, Vials, Cartridges, Other Products 2) By Molecule Type: Large Molecules, Small Molecules 3) By End-User: Biopharmaceutical Companies, Pharmaceutical Companies The global fill-finish pharmaceutical contract manufacturing market size is expected to grow from $10.02 billion in 2022 to $10.96 billion in 2023 at a compound annual growth rate (CAGR) of 9.40%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of fill-finish pharmaceutical contract manufacturing market is expected to reach $15.44 billion in 2027 at a CAGR of 8.94%. Increasing demand for pharmaceutical products is expected to propel the growth of the fill-finish pharmaceutical contract manufacturing market going forward. Pharmaceutical products refer to medications or drugs that are specifically formulated to diagnose, prevent, treat, or cure diseases or medical conditions in humans or animals. Fill-finish pharmaceutical contract manufacturing is a critical service used for the aseptic filling of injectables, biologics, and other pharmaceutical products, ensuring accuracy, regulatory compliance, and streamlined manufacturing processes while maintaining product quality. For instance, in June 2022, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical production in Europe accounted for $351 billion (€300,000 million) in 2021, with an increase of approximately 5% from $335.2 billion (€286,697 million) in 2020. Thus, R&D investment in the Spanish pharmaceutical business hit 1,267 million euros in 2021, a 9.2% increase over the previous year, 2020. Therefore, increasing demand for pharmaceutical products is driving the growth of the fill-finish pharmaceutical contract manufacturing market. Major players in the fill-finish pharmaceutical contract manufacturing market are AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Fresenius Kabi, Abbott Laboratories, Eurofins Scientific SE, Lonza Group Ltd., Catalent Inc., Sun Pharmaceutical Industries Limited, West Pharmaceutical Services Inc., Patheon, Samsung Biologics Co.Ltd., WuXi Biologics, Piramal Pharma Solutions, Pfizer CentreOne, Recipharm AB, Emergent BioSolutions Inc., Boehringer Ingelheim BioXcellence, Corden Pharma GmbH, Aenova Group, Baxter BioPharma Solutions, FUJIFILM Diosynth Biotechnologies, AGC Biologics, Rentschler Biopharma SE, Recro Pharma Inc., Cobra Biologics Limited, Grand River Aseptic Manufacturing (GRAM), MabPlex International Ltd., Cerbios-Pharma SA, and Symbiosis Pharmaceutical Services Limited. Technological advancements are a key trend gaining popularity in the fill-finish pharmaceutical contract manufacturing market. Companies operating in the fill-finish pharmaceutical contract manufacturing market are adopting innovative technologies to enhance product quality and comply with stringent regulatory requirements to sustain their position in the market. For instance, in January 2023, Steriline s.r.l., an Italy-based provider specializing in the production of aseptic solutions, launched robotic technologies tailored for small-batch aseptic filling, offering enhanced safety and flexibility in the production of both toxic and non-toxic pharmaceutical drugs. These innovative robotic systems are designed to minimize the risk of human error, improve overall product quality, and optimize operational efficiency. In October 2021, PCI Pharma Services (PCI), a US-based provider of outsourced pharmaceutical services, acquired Lyophilization Services of New England Inc. (LSNE) for $1.5 billion. The acquisition expands PCI's capabilities in sterile injectables, lyophilization, and specialized formulation development and manufacturing. LSNE's expertise in contract development and manufacturing services aligns with PCI's focus on delivering integrated solutions for pharmaceutical companies. Lyophilization Services of New England Inc. (LSNE) is a US-based contract development and manufacturing organization (CDMO) specializing in lyophilization, sterile fill-finish, and formulation development for pharmaceutical and biotechnology companies. North America was the largest region in the fill-finish pharmaceutical contract manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fill-finish pharmaceutical contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the fill-finish pharmaceutical contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The fill-finish pharmaceutical contract manufacturing market includes revenues earned by entities by providing septic filling, packaging, labeling, and serialization services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The fill-finish pharmaceutical contract manufacturing research report is one of a series of new reports from The Business Research Company that provides fill-finish pharmaceutical contract manufacturing market statistics, including the fill-finish pharmaceutical contract manufacturing industry's global market size, regional shares, competitors with a fill-finish pharmaceutical contract manufacturing market share, detailed fill-finish pharmaceutical contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the fill-finish pharmaceutical contract manufacturing industry. This fill-finish pharmaceutical contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Vaccine contract manufacturing refers to an arrangement for creating vaccines with outside producers, who oversee producing, packing, and labeling vaccines according to the specifications and demands of the contracting business or organization. The primary benefit of vaccine contract manufacturing is that it simplifies production, resulting in cost savings and fewer difficulties. The main types of services involved in vaccine contract manufacturing are fill-finish and bulk products. Fill-finish refers to the filling and finishing of the manufacturing process of vaccines. In the pharmaceutical industry, finishing refers to the sterilization and standardization of vaccine components into the containers, while filling means simply adding them to containers and sealing them properly. The vaccines produced are inactivated vaccines, live-attenuated vaccines, RNA (ribonucleic acid) vaccines, subunit vaccines, and toxoid-based vaccines. These are prepared by downstream and upstream processes on preclinical, clinical, and commercial scale of operations for human use and veterinary end-users. The global vaccine contract manufacturing market is segmented - 1) By Service Type: Fill-Finish, Bulk Product 2) By Vaccine Type: Inactivated Vaccines, Live-Attenuated Vaccines, RNA (Ribonucleic Acid) Vaccines, Subunit Vaccines, Toxoid-Based Vaccines 3) By Process: Downstream, Upstream 4) By Scale Of Operation: Preclinical, Clinical, Commercial 5) By End-Use: Human Use, Veterinary The global vaccine contract manufacturing market is expected to grow from $3 billion in 2022 to $3.30 billion in 2023 at a compound annual growth rate (CAGR) of 10%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global vaccine contract manufacturing is expected to reach $4.78 billion in 2027 at a CAGR of 9.7%. An increase in initiatives favoring vaccinations is expected to propel the growth of the vaccine contract manufacturing market going forward. Vaccination refers to an easy, safe, and efficient method of defending against contagious diseases before they occur. It boosts the immune system and builds up the body's defenses against infections. Increasing initiatives favoring vaccinations would help advance and develop various vaccine manufacturing processes to support vaccine contract manufacturing. For instance, in November 2022, the U.S. Department of Health and Human Services, a US-based cabinet-level executive branch department of the federal government, announced a new $350 million initiative for HRSA (Health Resources and Services Administration)-supported health facilities to boost the number of COVID-19 vaccines in their communities, with an emphasis on marginalized people. Therefore, the increase in initiatives favoring vaccinations is driving the growth of the vaccine contract manufacturing market. Major players in the vaccine contract manufacturing market are Pfizer Inc, Johnson & Johnson, AbbVie Inc., Sanofi, GlaxoSmithKline, Merck KGaA, Fujifilm Holdings Corporation, Moderna, BioNTech, GSK Vaccines, AstraZeneca PLC, Ajinomoto Co. Inc., Icon plc, Lonza Group AG, Cytiva, Catalent Inc., Charles River Laboratories International Inc., Serum Institute of India Pvt. Ltd, Samsung Biologics, WuXi Biologics, Novavax, Sinovac Biotech, Emergent BioSolutions Inc., Albany Molecular Research Inc., Soligenix Inc., Bio Farma, Curia Global Inc., Hualan Biological Engineering, BioMARC, Bavarian Nordic A/S, AGC Biologics, IDT Biologika GmbH, Bharat Biotech, Goodwin Biotechnology Inc., and Biofabri S.L. Strategic partnerships are a key trend gaining popularity in the vaccine contract manufacturing market. Significant companies are partnering with the companies operating in the vaccine contract manufacturing market to sustain their position in the market. For instance, in January 2023, Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, partnered with the Coalition for Epidemic Preparedness Innovations, a Norway-based foundation, to finance and coordinate the development of new vaccines and promote the development of Vaxxas' needle-free vaccine patch delivery technology in a project that may eliminate the frozen storage requirement for mRNA vaccines. Furthermore, in January 2021, Novartis AG, a Switzerland-based pharmaceutical company operating in the vaccine contract manufacturing market, partnered with Pfizer Inc., a US-based pharmaceutical company, and BioNTech SE, a Germany-based biotechnology company, to provide manufacturing capacity for the Pfizer-BioNTech COVID-19 vaccine. This partnership helps Novartis take bulk mRNA active ingredients from BioNTech and fill them into vials under aseptic conditions for shipment back to BioNTech for distribution to the healthcare system. In November 2021, CJ CheilJedang Corporation, a South Korea-based food and entertainment corporation, acquired Batavia Biosciences for $226 million. With this acquisition, CJ CheilJedang Corporation intends to expand the group's bio business portfolio and build synergies with other wellness-related companies in the long term. Batavia Biosciences is a Netherlands-based science-based contract development and manufacturing organization (CDMO) for viral vectors and vaccines, from process development to clinical and commercial manufacturing. North America was the largest region in the vaccine contract manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the vaccine contract manufacturing market report forecast period. The regions covered in vaccine contract manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the vaccine contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The vaccine contract manufacturing market consists of revenues earned by entities by providing services such as analytical, quality control studies, cell or virus banking, and cold chain services. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine contract manufacturing market also includes sales of synthetic vaccines and DNA (deoxyribonucleic acid) vaccines, which are used in providing vaccine contract manufacturing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The vaccine contract manufacturing research report is one of a series of new reports from The Business Research Company that provides vaccine contract manufacturing market statistics, including the vaccine contract manufacturing industry's global market size, regional shares, competitors with vaccine contract manufacturing market share, detailed vaccine contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine contract manufacturing industry. This vaccine contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Personal care contract manufacturing is when two businesses come to an arrangement to create parts or goods for personal care products over a certain period of time. The main product types included in the personal care contract manufacturing include skin care, hair care, make-up and cosmetics and other product types. Skincare products refers to products that are used on the skin to prevent acne, dark spots, and early signs of aging. The services included are research and development and formulation, manufacturing, packaging and allied services and the formulations include liquids, creams, lotions, oils and gels. The global personal care contract manufacturing market is segmented - 1) By Product Type: Skin Care, Hair Care, Make-Up And Cosmetics, Other Product Types 2) By Service Type: Research And Development And Formulation, Manufacturing, Packaging And Allied Services 3) By Formulation: Liquids, Creams, Lotions, Oils, Gels The global personal care contract manufacturing market size is expected to grow from $19.48 billion in 2022 to $21.07 billion in 2023 at a compound annual growth rate (CAGR) of 8.18%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global personal care contract manufacturing market size is expected to reach $29.65 billion in 2027 at a CAGR of 8.91%. The growth in the cosmetic industry is expected to propel the growth of the personal care contract manufacturing market in the coming future. Cosmetic industry deals with the production and sale of cosmetics, which are broadly defined as any kind of goods or concoctions intended to improve or complement a person's aesthetic or physical appearance. The increase in growth boosts the cosmetic industry as contract manufacturing makes cosmetic production easier to outsource, either completely or partially. For instance, in January 2022, according to Government of UK stats, the cosmetics and healthcare market was quickly expanding, exceeding many other retail sectors and being valued at $33.1 billion by 2022. Therefore, growth in the cosmetic industry is driving the market. Major players in the personal care contract manufacturing market are VVF Limited, A.I.G. Technologies Inc., Sarvotham Care Limited, Nutrix International LLC., Formula Corporation, Mansfield-King, Tropical Products Inc, Sensible Organics, Apollo Health and Beauty Care, McBride Plc, UNIVERSAL PACKAGING SYSTEMS INC., KIK Consumer Products Inc., Fareva, RCP Ranstadt GmbH and Skinlys. Product innovation is the key trend gaining popularity in the personal care contract manufacturing market. Major companies operating in the personal care contract manufacturing market are focused on developing innovative products to strengthen their position in the market. For instance, in March 2022, Colgate-Palmolive Company, a US-based company that manufactures personal care and oral hygiene products, launched Total Plaque Pro-Release toothpaste. Total Plaque Pro-Release toothpaste provides continuous, day-and-night antibacterial defense and has been clinically demonstrated to drastically reduce dangerous plaque bacteria between dental appointments. The revolutionary solution in Colgate Total Plaque Pro-Release employs Smart Foam Technology to access confined spaces and eliminate plaque bacteria at the gum line. This breakthrough recipe uses the strength of stannous fluoride, a chemical that helps decrease plaque bacteria and prevent gingivitis. In July 2021, PLZ Aeroscience Corporation, a US-based company that markets and manufactures aerosol products, acquired 220 Laboratories, Inc. for an undisclosed amount. Through this acquisition, PLZ Aeroscience Corporation can now provide its clients with a full range of services, ranging from custom aerosol and non-aerosol product manufacture to new product conceptualization and formula development. 220 Laboratories Inc. is a US-based personal care contract manufacturing company that specializes in aerosol and non-aerosol products for the hair, skin, and body. Asia-Pacific was the largest region in the personal care contract manufacturing market in 2022. Europe is expected to be the fastest-growing region in the global personal care contract manufacturing market report during the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the personal care contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The personal care contract manufacturing market consists of revenues earned by entities by providing personal care contract manufacturing services such as formulation development, product manufacturing and packaging. The market value includes the value of related goods sold by the service provider or included within the service offering. The Information technology market also includes sales of body care, oral care, sun care, and perfumes which are used in providing personal care contract manufacturing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The personal care contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides personal care contract manufacturing optical components market statistics, including personal care contract manufacturing optical components industry global market size, regional shares, competitors with a personal care contract manufacturing optical components market share, detailed personal care contract manufacturing optical components market segments, market trends and opportunities, and any further data you may need to thrive in the personal care contract manufacturing optical components industry. This personal care contract manufacturing optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Bakery contract manufacturing refers to a business approach where a bakery business enters into a production or service-related agreement with another business. Bakery contract manufacturers assist baking businesses by producing ingredients, packaging, or entire products according to the company's requirements. The main products of bakery contract manufacturing are specialty and nutritional bakery products and traditional bakery products. A specialized and nutritional bakery refers to a company that only produces one or a few types of baked goods. Specialty and nutritional bakeries benefit from the safe production and packaging provided by bakery contract manufacturers. The services offered include manufacturing, packaging, custom formulation, and R&D for various applications in small and medium enterprises (SMEs) and large enterprises. The global bakery contract manufacturing market is segmented - 1) By Product: Specialty And Nutritional Bakery Products, Traditional Bakery Products 2) By Service: Manufacturing, Packaging, Custom Formulation And R&D 3) By Application: Small And Medium Enterprises (SMEs), Large Enterprises The global bakery contract manufacturing market size is expected to grow from $19.92 billion in 2022 to $22.30 billion in 2023 at a compound annual growth rate (CAGR) of 11.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global bakery contract manufacturing market size is expected to reach $33.41 billion in 2027 at a CAGR of 10.6%. The rising consumption of bakery products is expected to boost the growth of the bakery contract manufacturing market going forward. Bakery products refer to a wide range of items that use wheat flour to produce various final bakery-related products. Since most bakeries cannot operate at full capacity to meet the increasing demand for bakery goods, they frequently turn to outside (contract manufacturing) companies to fill in the gaps on those lines; thus, rising bakery product consumption is expected to drive the bakery contract manufacturing market. For instance, according to a report published by the American Bakers Association, a US-based bakery-specific national and state trade association, in 2021, sales of baking ingredients and supplies increased by 18.7% and 16.3%, respectively, in 2020. Further, in October 2022, according to stats sourced from Euromonitor International, 2022 published on the Government of Canada's official website, retail sales of baked goods in the US reached $67.9 billion in 2021 and are expected to reach US$75.8 billion in 2026. Therefore, the rising consumption of bakery products is driving the growth of the bakery contract manufacturing market. Major players in the bakery contract manufacturing market are De Banketgroep B.V., HACO Holding AG, PacMoore Products Inc., Blackfriars Bakery, Southern Bakeries LLC, Cibus Nexum BV, Hearthside Food Solutions LLC, Richmond Baking, Oakhouse Bakery, Adventure Bakery LLC, Michel’s Bakery Inc., Bake Works Inc., Stephano Group Ltd., Tradition Fine Foods Ltd., and General Mills Inc. Technological advancement is the key trend gaining popularity in the bakery contract manufacturing market. Major companies operating in the bakery contract manufacturing market are focusing on developing new products. For instance, in September 2021, KPM Analytics, a US-based company operating in vision systems and automation inspection solutions to food manufacturers, launched the new Sightline TheiaVu Compact Vision Inspection Series with breadcrumb analysis capability. The Sightline TheiaVu Series Vision Inspection System is a fully competent benchtop analyzer for bakeries, snack food, and meat producers that measures size, shape, color, and toppings quickly, accurately, and consistently, ensuring final product quality. The crumb analysis capabilities further produce high-quality photos and data of bread items' internal crumb structure. The all-in-one tool delivers a wide range of data for testing, research, quality assurance, and final product inspection while reducing time for quality engineers. It is a valuable tool for increasing production, quality, and profits. In June 2021, Crown Bakeries, a US-based manufacturer of fresh and frozen bread, baked goods, and dough products, acquired Michel's Bakery Inc. for an undisclosed amount. The acquisition of Michel’s associates and their range of sweet baked products reinforces Crown's ambition to be recognized as the greatest custom baked goods supplier and employer in the industry. Michel's Bakery Inc. is a US-based provider of contract-manufacturing services. Europe was the largest region in the bakery contract manufacturing market in 2022. The regions covered in the global bakery contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bakery contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The bakery contract manufacturing market consists of revenues earned by entities by providing services such as label manufacturing, contract packaging (plastic, flow wrap, cartons), lab testing, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The bakery contract manufacturing market also includes sales of cookie dough, muffins, flatbreads and more baked goods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The bakery contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides bakery contract manufacturing market statistics, including the bakery contract manufacturing industry's global market size, regional shares, competitors with a bakery contract manufacturing market share, detailed bakery contract manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the bakery contract manufacturing industry. This bakery contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The food contract manufacturing are used to handle the manufacturing of food production activities through other agencies. This includes activities such as preparation of school food services, and in others, meals may be catered for an event. Food contract manufacturing refers to outsourcing in which one company hires another firm to manufacture food products. This helps the customer company focus more on branding and marketing. The main types of services in the food contract manufacturing market are manufacturing services, packaging services, and research and development. Manufacturing services refer to services that are used in the food industry as they allow for the avoidance of investments in food production and packaging machinery, facilities, resources, and highly skilled personnel. The various manufacturing processes include dry blending, spray drying, and extrusion. The global food contract manufacturing market is segmented - 1) By Services: Manufacturing Services, Packaging Services, Research and Development Services 2) By Manufacturing Process: Dry Blending, Spray Drying, Extrusion The global food contract manufacturing market size grew from $139.38 billion in 2022 to $154.23 billion in 2023 at a compound annual growth rate (CAGR) of 10.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services, and affecting many markets across the globe. The market size of the food contract manufacturing market is expected to grow to $220.43 billion in 2027 at a CAGR of 9.3%. Increasing food demand during the COVID-19 pandemic is expected to propel the growth of the food contract manufacturing market going forward. The SARS-CoV-2 virus causes the COVID-19 infectious disease. Most people infected with the virus experience mild to moderate respiratory illness. Taking healthy and hot food at regular intervals helps to reduce the effect of COVID-19 and boosts immunity, which has thus increased the demand for food. For instance, according to Oxford Press, a UK-based Oxford University Press, in 2020, in Europe, the demand for fresh bread increased by 76%, and frozen vegetables by 52%. Also, healthy food and beverage consumption increased, with vegetables by 33%, fruit by 29%, legumes by 26.5%, and extra virgin olive oil by 21.5%. Therefore, increased food demand during the pandemic is driving the growth of the food contract manufacturing market going forward. Major players in the food contract manufacturing market are Nutrascience Labs Inc., Pacmoore Products Inc., Thrive Foods LLC, Hearthside Food Solutions LLC, De Banketgroep B.V, Nu-World Foods, Fibro Foods, Tree Top Inc., Van Law Food Products Inc., Cremica Agro Foods Ltd., Sk Food Group, Haco AG, Hindustan Foods Limited, Christy Quality Foods, and Nikken Foods. New product innovations have emerged as the key trend gaining popularity in the food contract manufacturing market. Major companies operating in the food contract manufacturing sector are focused on developing new innovative products to increase their market share. For instance, in March 2022, EnWave Corporation, a Canada-based advanced technology company, launched its state-of-the-art vacuum-microwave toll drying facility, REVworx. This facility offers on-demand contract manufacturing services for the production of high-quality, vacuum-microwave dried snacks and ingredient applications for food companies of all sizes. REVwork uses REV technology that would lower the upfront capital investment and increase speed to market. In December 2021, Hearthside Foods Solutions, LLC, a US-based company operating in food contract manufacturing acquired Weston Foods Inc for a deal of $ 296 million. Through this acquisition, Hearthside Foods Solution aims to expand its production capabilities and enhance geographic coverage. Weston Food Inc is a Canada-based contract manufacturer of fresh and frozen baked products. North America was the largest region in the food contract manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food contract manufacturing market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the food contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The food contract manufacturing market includes revenues earned by entities by providng food product development, beverage formulation, microbiome solutions, nutraceutical formulations, herbal formulation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The food contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides food contract manufacturing market statistics, including food contract manufacturing industry global market size, regional shares, competitors with the food contract manufacturing market share, detailed food contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the food contract manufacturing industry. This food contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical device contract manufacturing refers to a process where a Medtech company that owns the idea (sole proprietorship) outsources manufacturing to another medical device manufacturing firm. The medical device contract manufacturing is used for the benefits of cost optimization, device upgrade, regulatory guidance, or expansion. The main devices of medical device contract manufacturing are IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopaedic devices, dental devices, and other devices. IVD devices refer to medical devices that are in vitro diagnostic medical devices (IVD) that are used alone or in combination with other diagnostic products for in vitro use, apparatus, equipment, or systems. The services are device development and manufacturing services, quality management services, and assembly services. The applications involved laparoscopy, pulmonary, urology, gynecology, and other applications. The global medical device contract manufacturing market is segmented - 1) By Device: IVD Devices, Diagnostic Imaging Devices, Cardiovascular Devices, Drug Delivery Devices, Endoscopy Devices, Ophthalmology Devices, Orthopedic Devices, Dental Devices, Other Devices 2) By Service: Device Development and Manufacturing Service, Quality Management Service, Assembly Service 3) By Application: Laparoscopy, Pulmonary, Urology, Gynecology, Other Applications The global medical device contract manufacturing market size grew from $76.83 billion in 2022 to $87.04 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the global medical device contract manufacturing is expected to grow to $141.27 billion in 2027 at a CAGR of 12.9%. The rising prevalence of chronic disorders is expected to propel the growth of the medical device contract manufacturing market going forward. Chronic diseases refer to conditions that require ongoing medical attention or limit activities. Smart medical devices help patients monitor their health conditions and better manage their chronic diseases. As a result, there is an increase in demand for medical device contract manufacturing. For instance, in 2020, according to the World Health Organization, a Switzerland-based government agency, chronic disease prevalence grew by 57% in the year 2020. Therefore, the rising prevalence of chronic disorders is driving the growth of the medical device contract manufacturing market. Major players in the medical device contract manufacturing market are Benchmark Electronics Inc., Celestica International Lp., Consort Medical PLC, Flex Ltd., Gerresheimer AG, Integer Holdings Corporation, Kimball Electronics Inc., Nemera Development S.A., Nipro Corporation, Nortech Systems Inc., Phillips-Medisize Corporation, Plexus Corporation, Sanmina Corporation, Biofortuna Limited, Catalent Inc., Forefront Medical Technologies Pte Ltd., Invetech, and SteriPack Group Ltd Technological innovations are the key trend gaining popularity in the medical device contract manufacturing market. Major companies operating in the medical device contract manufacturing market are focused on developing new technological solutions to strengthen their position. For instance, in December 2020, Forefront Medical Technology Pte Ltd., a Singapore-based company and medical device contract manufacturer, launched EzySwaba, a uniquely designed nasopharyngeal COVID-19 test swab. The EzySwab was developed to support the need for COVID-19 test swabs in the forefront of medical research in Singapore. This consists of the flexibility of biocompatible nylon for simple nasopharyngeal insertion and a safe breakpoint feature for rapid transfer to a sample collection tube. In August 2021, The Tecan Group, a Europe-based company provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics, acquired Paramit Corporation and its affiliates ("Paramit") for an amount of $1.0 billion. This acquisition brings significant engineering as well as cost-competitive manufacturing capabilities, both in North America and in the APAC region for Tecan. Paramit Corporation is a US-based medical device contract manufacturing firm. North America will be the largest region in the medical device contract manufacturing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical device contract manufacturing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the medical device contract manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The medical device contract manufacturing market includes revenues earned by entities by quality management system, ISO certified clean rooms, sterilization validation and recurring services, package design and testing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical device contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides medical device contract manufacturing market statistics, including medical device contract manufacturing industry global market size, regional shares, competitors with a medical device contract manufacturing market share, detailed medical device contract manufacturing market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract manufacturing industry. This medical device contract manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.